Gut Bacteria Metabolite PAA Drives Vascular Aging by Triggering Endothelial Senescence
A gut-derived metabolite called phenylacetic acid rises with age and causes blood vessel cells to senesce, linking the microbiome to cardiovascular aging.
Summary
Researchers discovered that phenylacetic acid (PAA), a metabolite produced by gut bacteria from phenylalanine, increases significantly with age in both humans and mice. Elevated PAA—linked to the bacterium Clostridium sp. ASF356—induces endothelial cell senescence by triggering mitochondrial hydrogen peroxide production and amplifying the senescence-associated secretory phenotype (SASP). Meanwhile, fecal acetate levels decline with age, removing a natural brake on senescence that operates via Sirt1-dependent pathways. Supplementing with sodium acetate countered PAA-induced senescence and restored angiogenic function, suggesting a microbiome-based therapeutic strategy for reducing vascular aging and associated cardiovascular disease risk.
Detailed Summary
Cardiovascular disease risk rises sharply with age, partly because endothelial cells lining blood vessels accumulate senescent cells that secrete inflammatory factors and lose their regenerative capacity. The gut microbiome produces hundreds of bioactive metabolites that enter circulation and influence vascular biology, yet its role in driving endothelial senescence has remained poorly understood.
This study found that plasma levels of phenylacetic acid (PAA) and its conjugate phenylacetylglutamine (PAGln) are markedly elevated in aged mice (>24 months) compared to young mice (>3 months), and similar age-associated increases were confirmed in the TwinsUK human cohort via nontargeted metabolomics. Metagenomic analyses revealed an age-related expansion of PAA-producing microbial pathways (porA/ppfor genes), positively correlated with the abundance of Clostridium sp. ASF356 (Clos). Colonizing young germ-free or antibiotic-treated mice with Clos raised circulating PAA and triggered endothelial senescence markers including p21, p16, γH2AX, and SA-β-galactosidase activity, along with impaired angiogenic sprouting.
Mechanistically, PAA was shown to stimulate mitochondrial H₂O₂ production in endothelial cells, activating a ROS-driven senescence cascade that amplified the SASP—including IL-6, IL-8, and MCP-1—creating a self-reinforcing pro-inflammatory environment. Genetic and pharmacological inhibition of mitochondrial ROS blunted PAA-induced senescence, confirming the mechanistic pathway.
In parallel, the study characterized the opposing role of acetate. Aging reduced fecal acetate levels by up to 80%, depleting a key senomorphic signal. Acetate normally suppresses SASP and maintains redox homeostasis through a Sirt1-dependent mechanism. Exogenous sodium acetate restored Sirt1 activity, reduced SASP output, and rescued angiogenic competence in PAA-exposed endothelial cells both in vitro and in aged mouse aortas in vivo.
These findings establish a dual microbiome axis in vascular aging: rising PAA acts as a pro-senescent signal while falling acetate removes a protective senomorphic brake. Sodium acetate supplementation emerges as a plausible, low-cost microbiome-based intervention to slow vascular aging. Caution is warranted, however, as most mechanistic data derive from mouse models and cell culture, and the causal role of PAA in human cardiovascular aging requires confirmation in prospective clinical studies.
Key Findings
- PAA and PAGln are elevated with age in humans (TwinsUK cohort) and mice, driven by Clostridium sp. ASF356.
- Colonizing young mice with Clos raises circulating PAA and induces endothelial senescence and impaired angiogenesis.
- PAA triggers senescence via mitochondrial H₂O₂ production, amplifying the pro-inflammatory SASP.
- Fecal acetate declines up to 80% with aging, removing Sirt1-dependent suppression of endothelial SASP.
- Sodium acetate supplementation rescues PAA-induced endothelial senescence and restores angiogenic function in aged mice.
Methodology
The study combined targeted and nontargeted metabolomics in aged vs. young C57BL/6 mice and the TwinsUK human cohort, metagenomics to map PAA-producing microbial pathways, and gnotobiotic/antibiotic-treated mouse colonization with Clostridium sp. ASF356. Mechanistic in vitro experiments used human umbilical vein and aortic endothelial cells exposed to PAA with mitochondrial ROS inhibitors, senescence biomarkers, and angiogenic assays.
Study Limitations
Causal evidence in humans is lacking; the TwinsUK association is observational. Most mechanistic data come from mouse colonization models and cultured endothelial cells, which may not fully recapitulate human vascular aging. The therapeutic dose and safety of long-term sodium acetate supplementation in humans have not been established.
Enjoyed this summary?
Get the latest longevity research delivered to your inbox every week.